Conflicts of interest may affect conclusions of systematic reviews of flu drugs, study indicatesBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6065 (Published 07 October 2014) Cite this as: BMJ 2014;349:g6065
- Michael McCarthy
Systematic reviews by authors with financial conflicts of interest gave favorable assessments of the use of neuraminidase inhibitors for the prevention and treatment of influenza more often than did reviews by authors without such conflicts, a new study has found.
Writing in the Annals of Internal Medicine, Adam Dunn of the Centre for Health Informatics at the University of New South Wales, Sydney, and colleagues noted that the role of neuraminidase inhibitors in the prevention and treatment of flu remained controversial and that the conclusions of review articles have ranged from strong endorsement of their use to assessments that questioned the drugs’ safety and efficacy.1 While acknowledging that there …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.